Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

W. L. GORE & ASSOCIATES, INC

US

Last updated September 17, 2026

Information

Country
US
Address
1505 NORTH FOURTH ST., FLAGSTAFF, AZ, 86004
Website
—
LinkedIn
—
Facebook
—
Email
—
Phone
—
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
2017233
DUNS Number
—

Catalogue (1343)

Page 12 of 27
DeviceModel / ReferenceRegistriesClassStatus
GORE EXCLUDER AAA Endoprosthesis PXT311417
FDA UDI
Class IIIUnknown
GORE TAG Thoracic Endoprosthesis TGT3115
FDA UDI
Class IIIUnknown
GORE MYCROMESH PLUS Biomaterial 1MYMP01
FDA UDI
Class IIUnknown
GORE® DrySeal Flex Introducer Sheath GDSF1233
FDA UDI
Class IIActive
GORE INTERING Vascular Graft IR06005045L
FDA UDI
Class IIUnknown
GORE-TEX Stretch Vascular Graft-Bifurcated SB2401D
FDA UDI
Class IIActive
GORE VIABAHN Endoprosthesis VBCR091502A
FDA UDI
Class IIIActive
GORE ENFORM Preperitoneal Biomaterial GBWR1016
FDA UDI
Class IIActive
GORE TAG Conformable Thoracic Endoprosthesis TGU404015
FDA UDI
Class IIIActive
GORE SEAMGUARD Bioabsorbable Staple Line Reinforce BSGTRI60BAC
FDA UDI
Class IIActive
GORE VIABAHN Endoprosthesis VBC100502A
FDA UDI
Class IIIActive
GORE ENFORM Preperitoneal Biomaterial GBWR3030
FDA UDI
Class IIActive
GORE EXCLUDER AAA Endoprosthesis with C3 Delivery RLT261214
FDA UDI
Class IIIActive
GORE-TEX Vascular Graft ST0602
FDA UDI
Class IIActive
Gore® Dualmesh® Plus Biomaterial 1DLMCP203
FDA UDI
Class IIUnknown
GORE VIABAHN Endoprosthesis VBCR060502A
FDA UDI
Class IIIActive
GORE-TEX Vascular Graft RRT06080090L
FDA UDI
Class IIUnknown
GORE-TEX Vascular Graft VT06050L
FDA UDI
Class IIActive
GORE TAG Thoracic Endoprosthesis TGT3715
FDA UDI
Class IIIUnknown
GORE TAG Thoracic Branch Endoprosthesis TAC083115A
FDA UDI
Class IIIActive
GORE VIABAHN Endoprosthesis with Heparin VBJR061502A
FDA UDI
Class IIIActive
GORE ACUSEAL Vascular Graft ECH460045A
FDA UDI
Class IIActive
GORE Hybrid Vascular Graft-CBAS 0650HYB0610A
FDA UDI
Class IIUnknown
GORE SYNECOR Preperitoneal Biomaterial GKWR2030
FDA UDI
Class IIActive
GORE VIABAHN Endoprosthesis with Heparin VBHR072502A
FDA UDI
Class IIIActive
GORE MYCROMESH PLUS Biomaterial 1MYMP08
FDA UDI
Class IIUnknown
GORE VIABAHN Endoprosthesis with Heparin VBHR061002A
FDA UDI
Class IIIActive
GORE VIABAHN VBX Balloon Expandable Endo BXB093902A
FDA UDI
Class IIIActive
GORE TAG Conformable Thoracic Endoprosthesis TGU404020
FDA UDI
Class IIIActive
GORE VIABAHN VBX Balloon Expandable Endo BXA075901A
FDA UDI
Class IIIActive
GORE VIABAHN VBX Balloon Expandable Endo BXAL082902A
FDA UDI
Class IIIActive
GORE-TEX Vascular Graft Pediatric Shunt VT35005LA
FDA UDI
Class IIActive
GORE PROPATEN Vascular Graft IRH473845A
FDA UDI
Class IIActive
GORE VIABAHN Endoprosthesis with Heparin VBHR062502A
FDA UDI
Class IIIActive
GORE-TEX Vascular Graft VT05040L
FDA UDI
Class IIUnknown
GORE VIABAHN VBX Balloon Expandable Endo BXB053901A
FDA UDI
Class IIIActive
GORE TAG Thoracic Branch Endoprosthesis TAC123415A
FDA UDI
Class IIIActive
GORE-TEX Vascular Graft SRRT06030080L
FDA UDI
Class IIActive
GORE PROPATEN Vascular Graft IRTH074040A
FDA UDI
Class IIActive
GORE-TEX Vascular Graft Pediatric Shunt VT35010LA
FDA UDI
Class IIActive
GORE-TEX Vascular Graft V45070L
FDA UDI
Class IIUnknown
GORE VIABAHN VBX Balloon Expandable Endo BXA051902A
FDA UDI
Class IIIActive
GORE VIABAHN Endoprosthesis with Heparin VBHR052502A
FDA UDI
Class IIIActive
GORE-TEX Stretch Vascular Graft S46045
FDA UDI
Class IIActive
GORE TAG Conformable Thoracic Endoprosthesis TGU212110
FDA UDI
Class IIIActive
GORE-TEX Stretch Vascular Graft S1203
FDA UDI
Class IIActive
GORE EXCLUDER AAA Endoprosthesis PXC231000
FDA UDI
Class IIIUnknown
GORE VIABAHN Endoprosthesis with Heparin VBJR060202A
FDA UDI
Class IIIActive
GORE-TEX Vascular Graft VT06040L
FDA UDI
Class IIActive
GORE VIABAHN VBX Balloon Expandable Endo BXB071901A
FDA UDI
Class IIIActive

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (28)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

DateRecall No.ClassStatusReason
Aug 26, 2025Z-0036-2026—open, classified

Reports of vascular graft delamination, which may lead to reduced access flow; cannulation difficulties; bleeding or bruising; and harms related to reintervention procedures, so Instructions for Use will be updated to modify existing warning to 1) further clarify techniques that may contribute to the risk of delamination, 2) Addition of delamination to device-related adverse event section.

Jul 3, 2024Z-2513-2024—open, classified

Devices were labeled with an expiration date of four years and ten days rather than the validated two years.

Jul 1, 2024Z-2946-2024—open, classified

Due to packaging defects, sterility assurance and heparin activity may be compromised.

Jul 1, 2024Z-2945-2024—open, classified

Due to packaging defects, sterility assurance and heparin activity may be compromised.

Jan 19, 2024Z-1179-2024—open, classified

Devices without transmural drainage holes may be mislabeled as devices with transmural drainage holes, or vice versa. Potential health impact includes extending procedure time, unplanned device removal, secondary procedure, cholangitis, cholecystitis, and/or pain. The GORE VIABIL Short Wire Biliary Endoprosthesis is a flexible, self-expanding endoprosthesis designed to maintain luminal patency of the common bile duct which may be obstructed. The endoprosthesis is radially compressed and secured onto the distal end of a catheter-based delivery system for deployment. The catheter provides a means for accessing and implanting the GORE VIABIL Short Wire Biliary Endoprosthesis at the target site in the biliary tract.

Dec 14, 2022Z-1048-2023—open, classified

Septal Occluders released with incomplete quality test documentation that assesses the release of the device from the delivery system during the index procedure. A potential failure of this quality test could potentially result could result in occluder embolization, anoxic brain injury, central venous or arterial perforation or rupture.

Sep 21, 2022Z-0136-2023—open, classified

Due to manufacturing records (Release Test Results) indicating "Failed".

Sep 7, 2021Z-0077-2022—open, classified

Incorrect labeling, specifically, expandable endoprosthesis labeled as 8 mm x 59mm x 135 cm, however may contain a 9mm x 29 mm x 135 cm device.

Sep 2, 2021Z-0171-2022—open, classified

Septal Occluders contain the incorrect expiration date. Product is labeled with a 3 yr. expiration date instead of 2 yrs.

Sep 2, 2021Z-0168-2022—open, classified

Septal Occluders contain the incorrect expiration date. Product is labeled with a 3 yr. expiration date instead of 2 yrs.

Sep 2, 2021Z-0169-2022—open, classified

Septal Occluders contain the incorrect expiration date. Product is labeled with a 3 yr. expiration date instead of 2 yrs.

Sep 2, 2021Z-0165-2022—open, classified

Septal Occluders contain the incorrect expiration date. Product is labeled with a 3 yr. expiration date instead of 2 yrs.

Sep 2, 2021Z-0170-2022—open, classified

Septal Occluders contain the incorrect expiration date. Product is labeled with a 3 yr. expiration date instead of 2 yrs.

Sep 2, 2021Z-0164-2022—open, classified

Septal Occluders contain the incorrect expiration date. Product is labeled with a 3 yr. expiration date instead of 2 yrs.

Sep 2, 2021Z-0172-2022—open, classified

Septal Occluders contain the incorrect expiration date. Product is labeled with a 3 yr. expiration date instead of 2 yrs.

Sep 2, 2021Z-0166-2022—open, classified

Septal Occluders contain the incorrect expiration date. Product is labeled with a 3 yr. expiration date instead of 2 yrs.

Sep 2, 2021Z-0167-2022—open, classified

Septal Occluders contain the incorrect expiration date. Product is labeled with a 3 yr. expiration date instead of 2 yrs.

Jul 12, 2021Z-2340-2021—open, classified

Complaints received concerning Balloon Catheter leakage from the guidewire lumen and the y-hub during preparation resulting in either insufficient inflation or an inability to inflate.

May 12, 2021Z-2293-2021—open, classified

Vascular Grafts containing an inner diameter of 6 mm may be incorrectly labeled as 5 mm and Vascular Grafts containing an inner diameter of 5 mm are incorrectly labeled as 6 mm.

May 12, 2021Z-2292-2021—open, classified

Vascular Grafts containing an inner diameter of 6 mm may be incorrectly labeled as 5 mm and Vascular Grafts containing an inner diameter of 5 mm are incorrectly labeled as 6 mm.

Apr 5, 2021Z-1593-2021—terminated

The Gore post market surveillance team received a complaint that a GORE VIABIL Biliary Endoprosthesis appeared shorter than the labeled length.

Sep 9, 2020Z-0290-2021—open, classified

Due to secondary deployment fiber being attached to secondary deployment handle, completion of deployment via the deployment line access hatch was not possible

Sep 9, 2020Z-0291-2021—open, classified

When the delivery catheter was attempted to be removed, there was an observed connection between the stent graft and the delivery catheter that prevented the delivery catheter from being withdrawn.

Jan 6, 2020Z-0996-2020—terminated

Firm has received reports of leading end catheter component separations.

Jan 6, 2020Z-0995-2020—terminated

Firm has received reports of leading end catheter component separations.

Dec 17, 2019Z-2052-2020—terminated

The incorrect label was placed on both the primary and secondary package.

Nov 18, 2019Z-1962-2020—terminated

The devices were mislabeled with the incorrect product size resulting in 16Fr devices being labeled as 14Fr devices.

Sep 25, 2017Z-0048-2018—terminated

Incomplete and/or partial deployment of the CTAG Device during the endovascular procedure.